MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0090067
Rene Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.78 Cr
▲ 1% YoY
Net profit · FY 2025
₹1.23 Cr
Net margin 7.3%
EBITDA · FY 2025
₹1.75 Cr
EBITDA margin 10.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹2.32 Cr
Satisfied ₹3.3 Cr
Company age
10 yrs
Est. 2016
Employees · EPFO
27
Provident fund records
About Rene Pharmaceuticals Private Limited
Data last updated:
Rene Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2016PTC274524. Its GSTIN is 27AAHCR6837Q1ZG (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Narendra Parshuram Shelar (Managing Director) and Nalamati Arun.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 206 Dimple Arcade Extension Building 10 Asha Nagar Kandivali East, Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.78 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹1.23 Cr (net margin 7.3%) and EBITDA of ₹1.75 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Renepharmaceuticals. As per MCA filings, the company has open charges of ₹2.32 Cr and satisfied charges of ₹3.3 Cr on record.
Rene Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0090067). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website renepharmaceuticals.in.
Company details
CIN U51101MH2016PTC274524
Registration Number 274524
Incorporation Date 17 March 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0090067
Recognitions & Rankings of Rene Pharmaceuticals
Contact details
Rene Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is renepharmaceuticals.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address206 Dimple Arcade Extension Building 10 Asha Nagar Kandivali East, Mumbai, Maharashtra, India – 400101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rene Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Rene Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Rene Pharmaceuticals operates one associated brand: Renepharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Trading and manufacturing of healthcare products for renal diseases and dialysis in India. | renepharmaceuticals.in |
Business activity
The main business activity of Rene Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rene Pharmaceuticals Private Limited, buy the company report.
Financials of Rene Pharmaceuticals Private Limited
FY 2025 filings availableRene Pharmaceuticals Private Limited reported revenue of ₹16.78 Cr (up 1% YoY) for FY 2025.
Revenue · FY 2025
₹16.78 Cr ▲ 1%
Net profit · FY 2025
₹1.23 Cr margin 7.3%
EBITDA · FY 2025
₹1.75 Cr margin 10.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 8%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 30%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 1% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.75 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 7.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rene Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rene Pharmaceuticals Private Limited
Rene Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Parshuram Shelar Also directs: Hemonc Pharma Private Limited | Managing Director | 17 Mar 2016 | 10 Years 7 Months | Current |
| Nalamati Arun Also directs: Bionic Meditech LLP, Assrmines and Minerals Private Limited, Bionic Medicare Private Limited and 1 more | Director | 23 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Rene Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nilsan Pharmaceuticals Private Limited | ₹17.12 Cr (FY 2025) | -9.0% | New Delhi, Delhi, India | |||
| Rene Pharmaceuticals Private Limitedthis company | ₹16.78 Cr (FY 2025) | ₹1.23 Cr | 7.3% | 1.0% | 27 | Mumbai, Maharashtra, India |
| Renocare Pharmaceuticals Private Limited | ₹16.58 Cr (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Jagrut Pharmaceuticals Private Limited | ₹16.54 Cr (FY 2019) | 7.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Rene Pharmaceuticals Private Limited, buy the company report.
Auditor
Rene Pharmaceuticals Private Limited is audited by MANOJ H CHOUDHARY & COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ H CHOUDHARY & COMPANY | FY 2022 | 016569C |
Shareholding
The shareholding of Rene Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rene Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.32 Cr
Satisfied charges
₹3.3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Jan 2024 | 100870174 | Axis Bank Limited | ₹2 Cr | Open | |
| 21 Oct 2023 | 100856719 | Hdfc Bank Limited | ₹31.63 Lakh | Open | |
| 25 Jan 2022 | 100547754 | Axis Bank Limited | ₹1.65 Cr | Satisfied | |
| 21 Jan 2022 | 100547755 | Axis Bank Limited | ₹1.65 Cr | Satisfied |
To see the full charge records of Rene Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Rene Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rene Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rene Pharmaceuticals Private Limited has a workforce of 27 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
27
Active EPFO establishments
1
Employee growth
8%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 27 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Rene Pharmaceuticals Private Limited, buy the company report.
GST
Rene Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR6837Q1ZG | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rene Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rene Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Nalamati Arun ceased to be Additional Director on 24 Sep 2017.
AGM
Rene Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rene Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Axis Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 100870174 was registered on 05 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 31.63 Lakh with Charge ID 100856719 was registered on 21 Oct 2023.
Charges
A charge registered on 25 Jan 2022 via Charge ID 100547754 with Axis Bank Limited was fully satisfied on 01 Feb 2023.
Charges
A charge registered on 21 Jan 2022 via Charge ID 100547755 with Axis Bank Limited was fully satisfied on 01 Feb 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 165.00 Lakh with Charge ID 100547754 was registered on 25 Jan 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 165.00 Lakh with Charge ID 100547755 was registered on 21 Jan 2022.
Ceased
Nalamati Arun ceased to be Additional Director.
Ceased
Ammanna Nalamati ceased to be Director.
Ceased
Madanmohan Fatehbir Bahadur ceased to be Director.
Appointed
Nalamati Arun was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Rene Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 March 2016 (10+ years old) and is registered under CIN U51101MH2016PTC274524.
Rene Pharmaceuticals has 2 current directors:
- Narendra Parshuram Shelar - Managing Director
- Nalamati Arun - Director
The latest financial statements of Rene Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Rene Pharmaceuticals is 27AAHCR6837Q1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rene Pharmaceuticals is U51101MH2016PTC274524. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rene Pharmaceuticals was incorporated on 17 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rene Pharmaceuticals by revenue are Nilsan Pharmaceuticals Private Limited, Renocare Pharmaceuticals Private Limited, Jagrut Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nalamati Arun ceased to be Additional Director on 24 Sep 2017. Ammanna Nalamati ceased to be Director on 25 Aug 2016. Madanmohan Fatehbir Bahadur ceased to be Director on 25 Aug 2016. Rene Pharmaceuticals has 5 board changes on record in total.
Yes, Rene Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0090067).
Rene Pharmaceuticals can be reached through the website renepharmaceuticals.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Rene Pharmaceuticals is at 206 Dimple Arcade Extension Building 10 Asha Nagar Kandivali East, Mumbai, Maharashtra, India – 400101.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages